Quick Answer
NOVAVAX INC reported Total Assets of $1.18 billion for the year ending 2025.
- NOVAVAX INC showed a decrease of -24.6% in Total Assets from 2024 to 2025.
- This data is from NOVAVAX INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $69.35 million | Q3 2011: $67.09 million | Q1 2012: $68.64 million | Q2 2012: $76.98 million | Q3 2012: $80.55 million | Q1 2013: $98.70 million | Q2 2013: $92.92 million | Q3 2013: $245.07 million | Q1 2014: $218.60 million | Q2 2014: $311.99 million | Q3 2014: $292.51 million | Q1 2015: $438.84 million | Q2 2015: $424.70 million | Q3 2015: $404.63 million | Q1 2016: $592.51 million | Q2 2016: $525.00 million | Q3 2016: $459.63 million | Q1 2017: $361.50 million | Q2 2017: $355.71 million | Q3 2017: $334.08 million | Q1 2018: $276.07 million | Q2 2018: $285.81 million | Q3 2018: $250.48 million | Q1 2019: $221.32 million | Q2 2019: $189.39 million | Q3 2019: $164.81 million | Q1 2020: $328.07 million | Q2 2020: $932.23 million | Q3 2020: $944.02 million | Q1 2021: $2.61 billion | Q2 2021: $2.75 billion | Q3 2021: $2.57 billion | Q1 2022: $2.83 billion | Q2 2022: $2.62 billion | Q3 2022: $2.27 billion | Q1 2023: $1.54 billion | Q2 2023: $1.69 billion | Q3 2023: $1.66 billion | Q1 2024: $1.35 billion | Q2 2024: $1.82 billion | Q3 2024: $1.71 billion | Q1 2025: $1.29 billion | Q2 2025: $1.34 billion | Q3 2025: $1.18 billion.
- Over the full 16 years of available data (2010 to 2025), NOVAVAX INC's Total Assets has grown by 1,472.0%.
- Historical annual values: Fiscal year 2025: $1.18 billion | Fiscal year 2024: $1.56 billion | Fiscal year 2023: $1.80 billion | Fiscal year 2022: $2.26 billion | Fiscal year 2021: $2.58 billion | Fiscal year 2020: $1.58 billion | Fiscal year 2019: $172.96 million | Fiscal year 2018: $207.98 million | Fiscal year 2017: $302.49 million | Fiscal year 2016: $394.30 million | Fiscal year 2015: $386.04 million | Fiscal year 2014: $276.00 million | Fiscal year 2013: $235.13 million | Fiscal year 2012: $102.35 million | Fiscal year 2011: $66.58 million | Fiscal year 2010: $74.84 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: